Surgical management of oligometastatic non-small cell lung cancer.

摘要: The oligometastatic stage IV non-small cell lung cancer (NSCLC) offers a new surgical opportunity. New reported data is showing that surgery can offer reasonable benefit, in terms of long-term survival, to some patients. advantages treatment rely on more adequate patient selection and better understanding the biology these tumors. Currently, mediastinal involvement primary tumor be identified as most important prognostic variable after curative-intent synchronous or metachronous metastasis. It seems clear routine use combined FDG-PET CT will help detect favorable cohort As expected, pathological T staging completeness its resection are also crucial factors influencing final results. real benefit local over metastasis controversial with series outcomes for lesions than others offering equal Also non conclusive results appear when analyzing different sites Retrospective tend show depending affected organ while usually no differences found prospective ones. Most current evidence based retrospective studies patients collected along extended periods time. That represents great limitation knowledge this topic. Some analyses have added insight, but still quality too low allow drawing robust conclusions. frequently concluded, well designed investigation requested ascertain value specific population NSCLC.